{"id":8391,"date":"2025-08-17T21:26:46","date_gmt":"2025-08-17T18:26:46","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8391"},"modified":"2025-08-17T21:26:46","modified_gmt":"2025-08-17T18:26:46","slug":"the-new-acc-aha-2025-hypertension-guidelines-scientific-summary","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/the-new-acc-aha-2025-hypertension-guidelines-scientific-summary\/","title":{"rendered":"The new ACC\/AHA 2025 Hypertension Guidelines Scientific Summary."},"content":{"rendered":"
The new ACC\/AHA 2025 Hypertension Guidelines Scientific Summary.<\/div>\n
Source& Date : Medscape,August 14, 2025.<\/div>\n
Key Points :<\/div>\n
<\/div>\n
1. Definition of Hypertension in the 2025 ACC\/AHA Guidelines(Same as AHA\/ACC 2017 ):<\/span><\/div>\n
\u2022 Normal BP: Less than 120\/80 mm\u202fHg<\/span><\/div>\n
\u2022 Elevated BP: 120\u2013129 mm\u202fHg systolic and <80 mm\u202fHg diastolic<\/span><\/div>\n
\u2022 Stage 1 Hypertension: 130\u2013139 mm\u202fHg systolic or 80\u201389 mm\u202fHg diastolic<\/span><\/div>\n
\u2022 Stage 2 Hypertension: \u2265140 mm\u202fHg systolic or \u226590 mm\u202fHg diastolicBP\u00a0<\/span><\/div>\n
\u00a0 \u00a0 \u00a0 \u2022\u00a0 \u00a0 Targets & Early Initiation<\/div>\n
\u2022 Treatment target remains <130\/80 mmHg for adults.<\/span><\/div>\n
\u2022 Drug therapy should begin earlier if BP \u2265130\/80 mmHg after 3\u20136 months of lifestyle changes.<\/span><\/div>\n
\u2022 Previous threshold (\u2265140\/90 mmHg) for primary prevention has been lowered.<\/span><\/div>\n
2. Immediate Therapy Indications<\/span><\/div>\n
\u2022 Initiate antihypertensive therapy promptly in patients with:<\/span><\/div>\n
* Diabetes mellitus<\/div>\n
* Chronic kidney disease<\/div>\n
* Elevated 10-year cardiovascular risk (using PREVENT calculator, AHA 2023).<\/div>\n
3. Optimal Goals<\/span><\/div>\n
\u2022 Clinicians should encourage achieving <120\/80 mmHg when possible for maximal risk reduction.<\/span><\/div>\n
\u2022 DASH diet (fruits, vegetables, low-fat dairy, fish, poultry, beans, nuts) continues to be strongly recommended.<\/span><\/div>\n
4. New Evidence Incorporated<\/span><\/div>\n
\u2022 Research from 2015\u20132024 integrated into guideline updates.<\/span><\/div>\n
\u2022 Emphasis on the link between hypertension and dementia: intensive BP control reduces dementia risk.<\/span><\/div>\n
\u2022 Lifestyle strategies (reduced salt, physical activity, weight loss, stress control) also shown to reduce cognitive decline.<\/span><\/div>\n
5. Laboratory & Diagnostic Updates<\/span><\/div>\n
\u2022 Urine albumin\/creatinine ratio testing (microalbuminuria) is now mandatory for all hypertensive(previously optional) :\u00a0<\/span><\/div>\n
* It\u2019s is an early warning sign of kidney injury, often before serum creatinine or eGFR abnormalities appear.<\/div>\n
Even small amounts of albumin in urine are strongly linked to higher risk of heart attack, stroke, and heart failure.<\/div>\n
* ACR therefore reflects not only kidney health but also overall vascular & organ damage.<\/div>\n
* Detecting albuminuria may change therapy: for example, adding ACE inhibitors or ARBs to protect kidneys and reduce cardiovascular risk.<\/div>\n
* Helps clinicians personalize treatment intensity in hypertensive patients.<\/div>\n
\u2022 Screening for primary aldosteronism in resistant hypertension is recommended, regardless of hypokalemia status.<\/span><\/div>\n
6. Lifestyle & Pharmacologic Strategies<\/span><\/div>\n
\u2022 Sodium intake recommendation reduced from 2300 mg\/day \u2192 1500 mg\/day.<\/span><\/div>\n
\u2022 No alcohol recommended for prevention\/management; if consumed:<\/span><\/div>\n
* Men: max 2 drinks\/day<\/div>\n
* Women: max 1 drink\/day (daily limit, not weekly average).<\/div>\n
\u2022 Weight loss is strongly endorsed; GLP-1 inhibitors may be considered if appropriate.<\/span><\/div>\n
7. Special Populations<\/span><\/div>\n
\u2022 Pregnancy: Low-dose aspirin recommended to prevent preeclampsia.<\/span><\/div>\n
\u2022 Hypertension in pregnancy predicts lifelong elevated BP risk.<\/span><\/div>\n
\u2022 The 2025 guidelines dedicate more focus to pregnancy compared with 2017.<\/span><\/div>\n
8. Therapeutic Innovations<\/span><\/div>\n
\u2022 Renal denervation mentioned as a possible adjunct to reduce medication need, but not formally recommended.<\/span><\/div>\n
\u2022 Tailored medication strategies emphasized for patient-specific care.<\/span><\/div>\n
<\/div>\n
https:\/\/www.medscape.com\/viewarticle\/bp-meds-should-begin-promptly-new-acc-aha-guidelines-say-2025a1000lms<\/a><\/div>\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

The new ACC\/AHA 2025 Hypertension Guidelines Scientific Summary. Source& Date : Medscape,August 14, 2025. Key Points : 1. Definition of Hypertension in the 2025 ACC\/AHA Guidelines(Same as AHA\/ACC 2017 ): \u2022 Normal BP: Less than 120\/80 mm\u202fHg \u2022 Elevated BP: 120\u2013129 mm\u202fHg systolic and <80 mm\u202fHg diastolic \u2022 Stage 1 Hypertension: 130\u2013139 mm\u202fHg systolic or […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8391","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8391"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8391\/revisions"}],"predecessor-version":[{"id":8392,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8391\/revisions\/8392"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}